121.03

1.53% 1.7933

Jazz Pharmaceuticals Plc (JAZZ)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$119.24

Aprire:

$121.84

Volume 24 ore:

101.88K

Relative Volume:

0.15

Capitalizzazione di mercato:

$7.21B

Reddito:

$3.91B

Utile/perdita netta:

$394.92M

Rapporto P/E:

-77.09

EPS:

-1.57

Flusso di cassa netto:

$1.02B

1 W Prestazione:

-2.58%

1M Prestazione:

+7.03%

6M Prestazione:

+13.18%

1 anno Prestazione:

+2.37%

Intervallo 1D:

$120.07

$122.03

Intervallo di 1 settimana:

$115.65

$123.19

Portata 52W:

$99.06

$134.17

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Nome

Jazz Pharmaceuticals Plc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

353-1-634-7800

Indirizzo

FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN

Dipendente

2,800

Cinguettio

@jazzpharma

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

JAZZ's Discussions on Twitter

Confronta JAZZ con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
JAZZ	121.09	7.21B	3.91B	394.92M	1.02B	-1.57
VRTX	447.41	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	742.11	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	589.03	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	250.03	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.69	24.49B	3.30B	-501.07M	1.03B	11.54

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-03	Iniziato	Robert W. Baird	Outperform
2023-11-27	Downgrade	UBS	Buy → Neutral
2023-09-29	Iniziato	Raymond James	Mkt Perform
2023-06-12	Ripresa	Wells Fargo	Equal Weight
2022-12-09	Aggiornamento	Goldman	Neutral → Buy
2022-06-14	Iniziato	UBS	Buy
2022-04-06	Downgrade	Goldman	Buy → Neutral
2021-11-19	Ripresa	Goldman	Buy
2021-10-07	Ripresa	Jefferies	Buy
2021-10-05	Iniziato	Citigroup	Buy
2021-09-23	Iniziato	Needham	Buy
2021-05-19	Ripresa	JP Morgan	Overweight
2021-04-07	Ripresa	RBC Capital Mkts	Outperform
2021-02-05	Reiterato	H.C. Wainwright	Buy
2021-02-03	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-01-29	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-12-16	Iniziato	UBS	Buy
2020-11-03	Reiterato	H.C. Wainwright	Buy
2020-10-09	Reiterato	H.C. Wainwright	Buy
2020-09-14	Downgrade	Goldman	Neutral → Sell
2020-09-14	Ripresa	JP Morgan	Overweight
2020-08-06	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-07-28	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-07-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-04-06	Iniziato	Jefferies	Buy
2020-03-12	Aggiornamento	Bernstein	Mkt Perform → Outperform
2020-01-08	Iniziato	Goldman	Neutral
2019-08-21	Downgrade	Piper Jaffray	Overweight → Neutral
2019-06-11	Iniziato	Barclays	Overweight
2019-03-20	Iniziato	SunTrust	Buy
2018-12-14	Iniziato	Wolfe Research	Peer Perform
2018-11-08	Reiterato	B. Riley FBR	Buy
2018-08-08	Reiterato	Stifel	Buy
2018-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2018-03-23	Reiterato	H.C. Wainwright	Neutral
2018-03-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight

Mostra tutto

Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie

09:09 AM

Pacer Advisors Inc. Buys 278,465 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

09:09 AM

08:57 AM

FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework - Benzinga

08:57 AM

08:10 AM

John G Ullman & Associates Inc. Sells 11,400 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

08:10 AM

06:53 AM

Jazz stock Zymeworks stock gain on FDA nod (JAZZ:NASDAQ) - Seeking Alpha

06:53 AM

06:00 AM

Zymeworks' Ziihera Wins FDA Approval: First Dual HER2 Cancer Drug Shows 52% Response Rate | ZYME Stock News - StockTitan

06:00 AM

01:33 AM

JAZZ (Jazz Pharmaceuticals) COGS-to-Revenue : 0.11 (As of Sep. 2024) - GuruFocus.com

01:33 AM

Nov 20, 2024

Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters.com

Nov 20, 2024

Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - JAZZ's Investor Relations

Nov 20, 2024

Nov 19, 2024

Jazz Pharmaceuticals to Present at Citi's 2024 Global Healthcare Conference | JAZZ Stock News - StockTitan

Nov 19, 2024

Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? - Yahoo Finance

Nov 19, 2024

Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment - Insider Monkey

Nov 19, 2024

Nov 18, 2024

Jazz Pharmaceuticals: High Uncertainty, Low Risk (undefined:JAZZ) - Seeking Alpha

Nov 18, 2024

Jazz Pharmaceuticals shares target raised on patient base growth By Investing.com - Investing.com UK

Nov 18, 2024

Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now? - Insider Monkey

Nov 18, 2024

Jazz Pharmaceuticals (NASDAQ:JAZZ) Given New $162.00 Price Target at Robert W. Baird - MarketBeat

Nov 18, 2024

Victory Capital Management Inc. Has $28.22 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 18, 2024

Nov 17, 2024

Jazz Tops Q3 Earnings & Sales Estimates, Raises '24 EPS View - MSN

Nov 17, 2024

Los Angeles Capital Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 17, 2024

Nov 16, 2024

Jazz Pharmaceuticals Plc: Its Efforts Towards Zepzelca Frontline Therapy Expansion & Other Major Drivers - Smartkarma

Nov 16, 2024

KBC Group NV Has $25.44 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 16, 2024

Principal Financial Group Inc. Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Idiopathic Hypersomnia Treatment Market will experience - openPR

Nov 15, 2024

Nov 14, 2024

Is the Options Market Predicting a Spike in Jazz (JAZZ) Stock? - Yahoo Finance

Nov 14, 2024

We Think Jazz Pharmaceuticals' (NASDAQ:JAZZ) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St

Nov 14, 2024

Jazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Nov 14, 2024

Jazz Pharmaceuticals' EVP Neena Patil sells $456,617 in shares By Investing.com - Investing.com Australia

Nov 14, 2024

Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) PT at $175.00 - MarketBeat

Nov 14, 2024

Nov 13, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Purchased by Kovack Advisors Inc. - MarketBeat

Nov 13, 2024

Wall Street Analysts See a 37.65% Upside in Jazz (JAZZ): Can the Stock Really Move This High? - Yahoo Finance

Nov 13, 2024

Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

American Assets Inc. Invests $557,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Jazz Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 11, 2024

Jazz Pharmaceuticals plc Updates Earnings Guidance for the Full Year 2024 - Marketscreener.com

Nov 11, 2024

Jazz (JAZZ) Reliance on International Sales: What Investors Need to Know - Yahoo Finance

Nov 11, 2024

Nov 10, 2024

28,693 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Bought by CWA Asset Management Group LLC - MarketBeat

Nov 10, 2024

Amalgamated Bank Sells 9,681 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 10, 2024

Nov 08, 2024

Philip James Wealth Mangement LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 08, 2024

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Van ECK Associates Corp Increases Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) - MarketBeat

Nov 08, 2024

Nov 07, 2024